Sort
4,870 grants matching “glp 1”
Development of small molecule therapeutics targeting AR-V7 for prostate cancer
$55,000Cheuk Man Cherie Au · Arma Bio, Inc. · R42 · FY2024 · CA
Cerebral Spinal Fluid Shunt System with Dual Lumen Distal Catheter Redundancy to Minimize Revision Surgery
$55,000Tom Viker · Cerovations, Llc · R43 · FY2020 · NS
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
$54,538Brianna Evans · Pennsylvania State Univ Hershey Med Ctr · F30 · FY2025 · DA
Associations of GLP-1-related genotypes with appetitive traits, food cue reactivity, and prospective weight gain in pre-adolescence
$54,538Timothy J Renier · Dartmouth College · F30 · FY2025 · DK
Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists
$54,500Konrad Talbot · Loma Linda University · R01 · FY2020 · AG
Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4)
$54,000Jessica Rose Wilson · Mayo Clinic Jacksonville · K23 · FY2022 · HL
Central GLP1 Signaling Pathways and Anxiety
$53,961Linda M Rinaman · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · MH
Associations of GLP-1-related genotypes with appetitive traits, food cue reactivity, and prospective weight gain in pre-adolescence
$53,774Timothy J Renier · Dartmouth College · F30 · FY2024 · DK
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 1/14/16)
$53,539Alan Carter · Midwest Research Institute · N01 · FY2018 · NS
Regulation of islet gap junction coupling and function under inflammatory conditions
$53,282Nikki L. Farnsworth · University Of Colorado Denver · F32 · FY2014 · DK
Histone Methylation: a role in excessive ethanol intake and self-administration
$53,282Jennifer Anne Rinker · Univ Of North Carolina Chapel Hill · F32 · FY2014 · AA
Investigation of the Therapeutic Potential of Fibroblast Activation Protein Inhibition in Type 2 Diabetes
$53,184Brandon Lee Panaro · Sinai Health System · F32 · FY2018 · DK
Metabolic Consequences of Neonatal Programming by a GLP1 Receptor Agonist
$53,174Daniella Angela Babu · University Of Pennsylvania · F32 · FY2010 · DK
Role of GLP-1 in Type 2 Diabetes Improvement After Roux-en-Y Gastric Bypass
$52,190Jill Carmody · Massachusetts General Hospital · F32 · FY2013 · DK
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 1/14/16)
$52,075Alan Carter · Midwest Research Institute · N01 · FY2017 · NS
Regulation of Intestinal PYY cell function
$52,066Diego V Bohorquez · Duke University · F32 · FY2011 · DK
Defining alpha-cell PC1/3 expression regulation for type 2 diabetes
$51,752Marlena Meta Holter · Cornell University · F30 · FY2022 · DK
HIV VACCINE PRODUCTION
$51,198Novartis Vaccines And Diagnostics, Inc. · N01 · FY2000 · AI
THE METFORMIN-EXENATIDE-INSULIN (MEXELIN) TRIAL
$50,936Robert E Ratner · Georgetown University · M01 · FY2009 · RR
Immune Monitoring and BiKE Production Core
$50,861Michael R Verneris · University Of Minnesota · P01 · FY2017 · CA
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 1/14/16)
$50,656Alan Carter · Midwest Research Institute · N01 · FY2016 · NS
Modulation of insulin and glucagon secretion by GPCR ligands
$50,538Tara Ashley Schwetz · Vanderbilt University · F32 · FY2011 · DK
Chemical control of protein stability to analyze germline cell fate
$50,474Jamie M Verheyden · University Of Wisconsin-Madison · F32 · FY2010 · GM
Investigation of the Therapeutic Potential of Fibroblast Activation Protein Inhibition in Type 2 Diabetes
$50,316Brandon Lee Panaro · Sinai Health System · F32 · FY2017 · DK
Functional and Behavioral Characterization of Central Amygdala Glucagon Like Peptode-1 Receptors
$50,256James Andrew Hardaway · University Of Alabama At Birmingham · R03 · FY2021 · DK